RadNet raises 2026 imaging guidance on AI rollout and JV expansion
Aug 9, 2026, 4:03 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Guidance upgrade plus AI rollout and expanded health-system partnerships improve both near-term visibility and long-term growth potential, supporting multiple expansion and higher cash-flow trajectory.
AI summary
What happened, with direct paths to the underlying reporting
RadNet posted a strong Q2 2026 with total revenue of $622.7M (+25% YoY) and record EBITDA levels, led by Imaging Center growth and a fast Digital Health ARR build to $105.5M. FDA clearance of DeepHealth breast ultrasound AI supports near-term rollout and potential cost savings, while a Boise JV with Saint Alphonsus expands RadNet’s health-system footprint. Management increased imaging-center guidance, signaling higher profit potential in H2 2026.
Q2 2026 total revenue $622.7M, up 25% YoY; imaging center growth drives gains.
Digital Health ARR reached $105.5M; external revenue about 63% of Digital Health Revenue.
DeepHealth AI cleared by FDA for breast ultrasound; rollout planned by year-end.
RadNet lifts 2026 imaging center guidance: revenue, EBITDA, and free cash flow up.
Boise joint venture with Saint Alphonsus; 157 of 442 locations in health-system partnerships.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Hunterbrook released a short report claiming RDNT's AI narrative is overstated. RadNet's stock price surged post-AI rebranding, but its core business remains low-margin. Less than…
- RadNet reported earnings of $0.07 per share, beating estimates by $0.16. - Company's revenues for quarter ended March 2024 were $431.71 million, beating expectations. - RadNet s…